In vivo regulation of matrix vesicle concentration and enzyme activity during primary bone formation

Bone Miner. 1992 May;17(2):134-8. doi: 10.1016/0169-6009(92)90724-r.

Abstract

In vivo regulation of matrix vesicles (MV) during primary bone formation was examined using tibial marrow ablation in rats as the experimental model. The effects of bone-bonding and nonbonding implants on the number of MV/micron 2 of matrix and the alkaline phosphatase (ALPase) and phospholipase A2 (PA2) activities of MV-enriched microsomes (MVEM) isolated from the healing bone were studied. MV concentration, ALPase, and PA2 were increased by bone-bonding implants by day 3 post-surgery; a similar effect was seen in the contralateral limb, but at a lower magnitude. Nonbonding implants had no effect at day 3 and decreased MV concentration and PA2 activity at later time points; the same behavior was observed in the contralateral limb. These results demonstrate that MVs are influenced in a differential manner by implant materials, both locally and systemically, and can be regulated during primary mineralization.

MeSH terms

  • Alkaline Phosphatase / metabolism
  • Animals
  • Biocompatible Materials
  • Bone Matrix / enzymology
  • Bone Matrix / ultrastructure*
  • Ceramics
  • Male
  • Microsomes / enzymology
  • Osteogenesis / physiology*
  • Phospholipases A / metabolism
  • Phospholipases A2
  • Prostheses and Implants
  • Rats
  • Stainless Steel
  • Titanium

Substances

  • Biocompatible Materials
  • Stainless Steel
  • Titanium
  • Phospholipases A
  • Phospholipases A2
  • Alkaline Phosphatase